In order to compare the characteristics of trazodone (in the dose range of 150-450 mg) and second-generation AD, several direct comparative studies were carried out with the participation of people with MDD. An analysis of trials comparing different second-generation BPs demonstrated that the response to therapy was comparable between trazodone and other second-generation BPs, including …
Continue reading “Comparative analysis of trazodone and second-generation Antidepressants”